Reduction of Double-Stranded RNA-Activated Protein Kinase in Hepatocellular Carcinoma Associated with Hepatitis B Virus

Journal of Medical Virology

Volumn 73, Issue 2, 2004, Pages 187-194

  Chen, George G ^a   Lai, Paul B S ^a   Ho, Rocky L K ^a   Chan, Paul K S ^a   Xu, H ^a   Wong, John ^a   Lau, Wan Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Alpha fetoprotein; Hepatitis B virus; Hepatocellular carcinoma; PKR

Indexed keywords

ALPHA FETOPROTEIN; CELL PROTEIN; DOUBLE STRANDED RNA; INTERFERON; PROTEIN KINASE; PROTEIN KINASE R; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; ENZYME ASSAY; FEMALE; GROWTH REGULATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; VIRUS INHIBITION; VIRUS LOAD;

ADULT; AGED; ALPHA-FETOPROTEINS; BIOPSY; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; EIF-2 KINASE; FEMALE; GENE EXPRESSION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 2142660709     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20074     Document Type: Article

References (30)

1. Ahn JY, Jung EY, Kwun HJ, Lee CW, Sung YC, Jang KL. 2002. Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53. J Gen Virol 83(Pt 11):2765-2772.
2. Arima T, Nakao K, Nakata K, Ishikawa H, Ichikawa T, Hamasaki K, Ishii N, Eguchi K. 2002. Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells. Int J Mol Med 9(4):397-400.
3. Barber GN, Wambach M, Thompson S, Jagus R, Katze MG. 1995. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol 15(6):3138-3146.
4. Benn J, Schneider RJ. 1995. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci USA 92(24): 11215-11219.
5. Bouchard MJ, Wang LH, Schneider RJ. 2001. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294(5550):2376-2378.
6. Cai R, Carpick B, Chun RF, Jeang KT, Williams BR. 2000. HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch Biochem Biophys 373(2):361-367.
7. Chen GG, Lai PB, Chan PK, Chak EC, Yip JH, Ho RL, Leung BC, Lau WY. 2001. Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein. Eur J Cancer 37(13):1695-1702.
8. Cuddihy AR, Li S, Tam NW, Wong AH, Taya Y, Abraham N, Bell JC, Koromilas A.E. 1999. Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol 19(4):2475-2484.
9. Deb A, Zamanian-Daryoush M, Xu Z, Kadereit S, Williams BR. 2001. Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. EMBO J 20(10):2487-2496.
10. Delhem N, Sabile A, Gajardo R, Podevin P, Abadie A, Blaton MA, Kremsdorf D, Beretta L, Brechot C. 2001. Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene 20(41): 5836-5845.
11. Dotsch J, Harmjanz A, Christiansen H, Hanze J, Lampert F, Rascher W. 2000. Gene expression of neuronal nitric oxide synthase and adrenomedullin in human neuroblastoma using real-time PCR. Int J Cancer 88(2):172-175.
12. Gale M, Jr., Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG. 1998. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation. Mol Cell Biol 18(9): 5208-5218.
13. Gil J, Esteban M. 2000. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action. Apoptosis 5(2):107-114.
14. Guidotti LG, Morris A, Mendez H, Koch R, Silverman RH, Williams BR, Chisari FV. 2002. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J Virol 76(6): 2617-2621.
15. Heid CA, Stevens J, Livak KJ, Williams PM. 1996. Real time quantitative PCR. Genome Res 6(10):986-994.
16. Hendricks DA, Stowe BJ, Hoo BS, Kolberg J, Irvine BD, Neuwald PD, Urdea MS, Perrillo RP. 1995. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 104(5):537-546.
17. Johnson PJ. 2001. The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Disease 5(1):145-159.
18. Kew MC, Ray MB, Desmet VJ, Desmyter J. 1980. Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma. Br J Cancer 41(3):399-406.
19. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N. 1992. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257(5077):1685-1689.
20. Krajden M, Comanor L, Rifkin O, Grigoriew A, Minor JM, Kapke GF. 1998. Assessment of hepatitis B virus DNA stability in serum by the Chiron Quantiplex branched-DNA assay. J Clin Microbiol 36(2): 382-386.
21. Lee KC, Crowe AJ, Barton MC. 1999. p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol Cell Biol 19(2):1279-1288.
22. MacQuillan GC, de Boer WB, Platten MA, McCaul KA, Reed WD, Jeffrey GP, Allan JE. 2002. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection. J Med Virol 68(2): 197-205.
23. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG. 1993. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90(1):232-236.
24. Patel CV, Handy I, Goldsmith T, Patel RC. 2000. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J Biol Chem 275(48):37993-37998.
25. Raveh T, Hovanessian AG, Meurs EF, Sonenberg N, Kimchi A. 1996. Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons. J Biol Chem 271(41): 25479-25484.
26. Romano PR, Garcia-Barrio MT, Zhang X, Wang Q, Taylor DR, Zhang F, Herring C, Mathews MB, Qin J, Hinnebusch AG. 1998. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol Cell Biol 18(4):2282-2297.
27. Shimada A, Shiota G, Miyata H, Kamahora T, Kawasaki H, Shiraki K, Hino S, Terada T. 1998. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res 58(19): 4434-4438.
28. Tabor E. 1994. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 42(4):357-365.
29. Tanaka Y, Esumi M, Shikata T. 1988. Frequent integration of hepatitis B virus DNA in noncancerous liver tissue from hepatocellular carcinoma patients. J Med Virol 26(1):7-14.
30. Waris G, Huh KW, Siddiqui A. 2001. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 21(22):7721-7730.